JPY1,630.50
0.06% yesterday
Tokyo, Dec 30, 07:07 am CET
ISIN
JP3197600004
Symbol
4528
Sector
Industry

Ono Pharmaceutical Target price 2024 - Analyst rating & recommendation

Ono Pharmaceutical Classifications & Recommendation:

Buy
9%
Hold
45%
Sell
45%

Ono Pharmaceutical Price Target

Target Price JPY1,860.00
Price JPY1,634.50
Potential
Number of Estimates 10
10 Analysts have issued a price target Ono Pharmaceutical 2025 . The average Ono Pharmaceutical target price is JPY1,860.00. This is higher than the current stock price. The highest price target is
JPY2,500.00 52.95%
register free of charge
, the lowest is
JPY1,400.00 14.35%
register free of charge
.
A rating was issued by 11 analysts: 1 Analysts recommend Ono Pharmaceutical to buy, 5 to hold and 5 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ono Pharmaceutical stock has an average upside potential 2025 of . Most analysts recommend the Ono Pharmaceutical stock at Sell or hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '24 2025
Estimates
Revenue Billion JPY 502.67 490.50
12.41% 2.42%
EBITDA Margin 36.15% 24.04%
4.77% 33.49%
Net Margin 24.91% 12.54%
2.74% 49.66%

10 Analysts have issued a sales forecast Ono Pharmaceutical 2025 . The average Ono Pharmaceutical sales estimate is

JPY491b
Unlock
. This is
1.28% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY518b 6.86%
Unlock
, the lowest is
JPY477b 1.42%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 JPY503b 12.41%
2025
JPY491b 2.42%
Unlock
2026
JPY518b 5.66%
Unlock
2027
JPY529b 2.09%
Unlock
2028
JPY522b 1.29%
Unlock
2029
JPY517b 1.04%
Unlock

8 Analysts have issued an Ono Pharmaceutical EBITDA forecast 2025. The average Ono Pharmaceutical EBITDA estimate is

JPY118b
Unlock
. This is
16.03% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
JPY144b 2.32%
Unlock
, the lowest is
JPY95.3b 32.14%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 JPY182b 7.04%
2025
JPY118b 35.11%
Unlock
2026
JPY129b 9.82%
Unlock
2027
JPY131b 1.50%
Unlock
2028
JPY142b 7.74%
Unlock
2029
JPY138b 2.47%
Unlock

EBITDA Margin

2024 36.15% 4.77%
2025
24.04% 33.49%
Unlock
2026
24.98% 3.91%
Unlock
2027
24.84% 0.56%
Unlock
2028
27.11% 9.14%
Unlock
2029
26.72% 1.44%
Unlock

4 Ono Pharmaceutical Analysts have issued a net profit forecast 2025. The average Ono Pharmaceutical net profit estimate is

JPY61.5b
Unlock
. This is
34.96% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY64.6b 31.72%
Unlock
, the lowest is
JPY56.8b 39.99%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 JPY125b 15.49%
2025
JPY61.5b 50.88%
Unlock
2026
JPY62.9b 2.26%
Unlock
2027
JPY64.4b 2.44%
Unlock

Net Margin

2024 24.91% 2.74%
2025
12.54% 49.66%
Unlock
2026
12.14% 3.19%
Unlock
2027
12.18% 0.33%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '24 2025
Estimates
Earnings Per Share JPY 266.61 130.96
15.49% 50.88%
P/E 12.46
EV/Sales 1.53

4 Analysts have issued a Ono Pharmaceutical forecast for earnings per share. The average Ono Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

JPY130.96
Unlock
. This is
34.96% lower
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
JPY137.48 31.72%
Unlock
, the lowest is
JPY120.83 39.99%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 JPY266.61 15.49%
2025
JPY130.96 50.88%
Unlock
2026
JPY133.92 2.26%
Unlock
2027
JPY137.18 2.43%
Unlock

P/E ratio

Current 8.10 15.98%
2025
12.46 53.83%
Unlock
2026
12.18 2.25%
Unlock
2027
11.89 2.38%
Unlock

Based on analysts' sales estimates for 2025, the Ono Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.55 28.24%
2025
1.53 1.03%
Unlock
2026
1.45 5.35%
Unlock
2027
1.42 2.05%
Unlock
2028
1.44 1.30%
Unlock
2029
1.46 1.05%
Unlock

P/S ratio

Current 1.58 34.57%
2025
1.56 1.26%
Unlock
2026
1.48 5.35%
Unlock
2027
1.45 2.05%
Unlock
2028
1.47 1.30%
Unlock
2029
1.48 1.05%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today